Malin Corporation | MLC - Cash And Equivalent

Stock Price
7.95
Daily Change
0.10 1.27%
Monthly
3.25%
Yearly
-22.06%
Q1 Forecast
7.76

Malin Corporation reported EUR62.1M in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
ALKERMES USD 616.45M 95.25M Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Eurofins Scientific SE EUR 753.3M 139.4M Jun/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
IQVIA Holdings USD 1.81B 225M Sep/2025
Lonza CHF 1.11B 286M Dec/2024
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 1.13B 147M Sep/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Viatris USD 975.3M 408.9M Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025